Showing results (3461-3470 of 9,925) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|March 14, 2017
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantationG M Dotoli, G C De Santis, M D Orellana, et al.
Bone Marrow Transplantation|December 13, 2016
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomesH Pourhassan, T DeFor, B Trottier, et al.
Bone Marrow Transplantation|December 13, 2016
Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantationS Fuji, J Löffler, B N Savani, et al.
Bone Marrow Transplantation|December 13, 2016
Haploidentical transplantation for pediatric patients with acquired severe aplastic anemiaL P Xu, X H Zhang, F R Wang, et al.
Bone Marrow Transplantation|December 13, 2016
Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigueS E Ghazikhanian, C S Dorfman, T J Somers, et al.
Bone Marrow Transplantation|December 13, 2016
Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experienceA-L Alloin, G Leverger, J-H Dalle, et al.
Bone Marrow Transplantation|December 20, 2016
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsB S Andersson, P F Thall, B C Valdez, et al.
Bone Marrow Transplantation|July 1, 1989
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host diseaseG Laurent, D Maraninchi, E Gluckman, et al.
Bone Marrow Transplantation|September 1, 1989
Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantationM C Favrot, D Floret, S Negrier, et al.
Bone Marrow Transplantation|September 1, 1989
An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097H O Ito, J Morizet, L Coulombel, et al.
Pageof 993